Empirical antifungal therapy in neutropaenic cancer patients with persistent fever

This publication has 28 references indexed in Scilit:

• 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
  Clinical Infectious Diseases, 2002
• Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with Leukemia
  Leukemia & Lymphoma, 2001
• Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections
  British Journal of Haematology, 1998
• Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation
  The Journal of Infectious Diseases, 1997
• Fungal infections in cancer patients: An international autopsy survey
  European Journal of Clinical Microbiology & Infectious Diseases, 1992
• The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B
  Journal of Infection, 1991
• Empiric antifungal therapy in febrile granulocytopenic patients
  The American Journal of Medicine, 1989
• Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients
  Antimicrobial Agents and Chemotherapy, 1987
• Fungal infections in patients with acute leukemia
  The American Journal of Medicine, 1982
• Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
  The American Journal of Medicine, 1982